US Physical Therapy Analyst Ratings
US Physical Therapy Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/22/2023 | 14% | JP Morgan | → $108 | Initiates Coverage On | → Overweight |
| 09/19/2023 | — | CJS Securities | Upgrades | Market Perform → Market Outperform | |
| 08/14/2023 | 30.88% | Barrington Research | $116 → $124 | Maintains | Outperform |
| 06/30/2023 | 45.66% | B of A Securities | → $138 | Initiates Coverage On | → Buy |
| 05/05/2023 | 22.44% | Barrington Research | $110 → $116 | Maintains | Outperform |
| 02/24/2023 | 16.11% | Barrington Research | $107 → $110 | Maintains | Outperform |
| 12/14/2021 | 26.66% | CJS Securities | → $120 | Upgrades | Market Perform → Market Outperform |
| 05/07/2021 | 37.22% | Barrington Research | → $130 | Upgrades | Market Perform → Outperform |
| 05/03/2021 | 42.5% | Jefferies | $130 → $135 | Upgrades | Hold → Buy |
| 02/26/2021 | — | Barrington Research | Downgrades | Outperform → Market Perform | |
| 03/27/2020 | -15.56% | Sidoti & Co. | $128 → $80 | Maintains | Buy |
| 11/08/2019 | 37.22% | Barrington Research | → $130 | Upgrades | Market Perform → Outperform |
| 03/08/2019 | — | William Blair | Initiates Coverage On | → Outperform | |
| 11/02/2018 | 12.94% | Cantor Fitzgerald | $103 → $107 | Maintains | Neutral |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 09/22/2023 | 百分之十四 | 摩根大通 | →$108 | 开始承保 | →超重 |
| 2023/09/19 | - | CJS证券 | 升级 | 市场表现优于→市场表现 | |
| 2023年08月14日 | 30.88% | 巴灵顿研究公司 | $116→$124 | 维护 | 跑赢大盘 |
| 2023/06/30 | 45.66% | B of A证券 | →$138 | 开始承保 | →购买 |
| 05/05/2023 | 22.44% | 巴灵顿研究公司 | $110→$116 | 维护 | 跑赢大盘 |
| 02/24/2023 | 16.11% | 巴灵顿研究公司 | $107→$110 | 维护 | 跑赢大盘 |
| 2021年12月14日 | 26.66% | CJS证券 | →$120 | 升级 | 市场表现优于→市场表现 |
| 05/07/2021 | 37.22% | 巴灵顿研究公司 | →$130 | 升级 | 市场表现优于→ |
| 05/03/2021 | 42.5% | 杰富瑞 | $130→$135 | 升级 | 持有→购买 |
| 02/26/2021 | - | 巴灵顿研究公司 | 评级下调 | 跑赢→市场表现 | |
| 03/27/2020 | -15.56% | 西多蒂公司 | $128→$80 | 维护 | 买 |
| 2019年8月11日 | 37.22% | 巴灵顿研究公司 | →$130 | 升级 | 市场表现优于→ |
| 2019年03月08日 | - | 威廉·布莱尔 | 开始承保 | →跑赢大盘 | |
| 11/02/2018 | 12.94% | 康托·菲茨杰拉德 | $103→$107 | 维护 | 中性 |
What is the target price for US Physical Therapy (USPH)?
美国理疗(USPH)的目标价格是多少？
The latest price target for US Physical Therapy (NYSE: USPH) was reported by JP Morgan on September 22, 2023. The analyst firm set a price target for $108.00 expecting USPH to rise to within 12 months (a possible 14.00% upside). 6 analyst firms have reported ratings in the last year.
摩根大通于2023年9月22日报道了美国物理疗法(纽约证券交易所代码：USPH)的最新目标价格。这家分析公司将目标价定为108.00美元，预计美元兑美元汇率将在12个月内上涨至14.00%。6家分析公司在过去一年公布了评级。
What is the most recent analyst rating for US Physical Therapy (USPH)?
分析师对美国理疗(USPH)的最新评级是多少？
The latest analyst rating for US Physical Therapy (NYSE: USPH) was provided by JP Morgan, and US Physical Therapy initiated their overweight rating.
美国物理治疗公司(纽约证券交易所代码：USPH)的最新分析师评级是由摩根大通提供的，美国物理治疗公司启动了他们的增持评级。
When is the next analyst rating going to be posted or updated for US Physical Therapy (USPH)?
美国理疗(USPH)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of US Physical Therapy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for US Physical Therapy was filed on September 22, 2023 so you should expect the next rating to be made available sometime around September 22, 2024.
分析师在进行了广泛的研究后得出了股票评级，这些研究包括查阅公共财务报表，与美国理疗公司的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。美国物理治疗的上一次评级是在2023年9月22日提交的，所以你应该预计下一次评级将在2024年9月22日左右公布。
Is the Analyst Rating US Physical Therapy (USPH) correct?
分析师对美国理疗(USPH)的评级正确吗？
While ratings are subjective and will change, the latest US Physical Therapy (USPH) rating was a initiated with a price target of $0.00 to $108.00. The current price US Physical Therapy (USPH) is trading at is $94.74, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但美国最新的理疗评级是以0.00美元至108.00美元的目标价启动的。目前美国理疗(USPH)的交易价格为94.74美元，在分析师的预测范围内。